Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
US9862934B2 · kind B2 · utility
2Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2015 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Mar 27, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/50
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reduced number of or without contaminating baculoviral virions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.